首页> 外文期刊>Gastroenterology research and practice >Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B
【24h】

Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B

机译:乙型肝炎病毒相关性肾小球肾炎:不是韩国慢性乙型肝炎患者蛋白尿的主要原因

获取原文
           

摘要

Background/Aims. Hepatitis B virus (HBV) can form immune complexes which may result in various types of glomerulonephritis (GN). However, proteinuria can occur because of other kidney diseases besides HBV-related GN (HBV-GN). The aim of this study is to elucidate the causes of proteinuria and report on the clinical outcomes of HBV-GN.Methods. We reviewed the medical records of patients positive for serum hepatitis B surface antigen who underwent renal biopsies due to proteinuria at a tertiary medical center in Korea.Results. A total of 55 patients were included. HBV-GN was diagnosed in 20 (36.4%) of the patients by confirming the presence of immune complexes (12 of 13 membranoproliferative glomerulonephritis, 7 of 8 membranous glomerulonephritis, and 1 of 13 immunoglobulin A nephropathy). Twenty-one patients had other types of GN. A total of 13 (65%) HBV-GN patients were treated with antiviral agents for a median of 11 months. However, the degrees of proteinuria were not significantly reduced in the antiviral intervention group when compared to the control group.Conclusions. Proteinuria can be caused by various glomerular diseases and HBV-GN accounts for one-third of total GN cases. Well-designed prospective study is needed to assess whether antiviral therapy against HBV infection may improve the prognosis of HBV-GN.
机译:背景/目标。乙型肝炎病毒(HBV)可以形成免疫复合物,可能导致各种类型的肾小球肾炎(GN)。但是,由于与HBV相关的GN(HBV-GN)以外的其他肾脏疾病,也可能发生蛋白尿。这项研究的目的是阐明蛋白尿的原因并报告HBV-GN的临床结局。我们在韩国一家三级医疗中心检查了因蛋白尿而接受肾活检的血清B型肝炎表面抗原阳性患者的病历。总共包括55名患者。通过确认存在免疫复合物(13例膜增生性肾小球肾炎,12例8膜性肾小球肾炎和13例免疫球蛋白A肾病)的存在,在20例(36.4%)患者中诊断出HBV-GN。 21名患者患有其他类型的GN。共有13名(65%)HBV-GN患者接受了抗病毒药物治疗,中位时间为11个月。然而,与对照组相比,抗病毒干预组的蛋白尿程度并未显着降低。蛋白尿可由各种肾小球疾病引起,HBV-GN占总GN病例的三分之一。需要进行精心设计的前瞻性研究来评估针对HBV感染的抗病毒治疗是否可以改善HBV-GN的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号